Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Altabás‐González
Observed names:
Irene Altabás,
Irene Altabás González,
Irene Altabás-González
Institution:
University Hospital Complex Of Vigo
Observed institutions:
University Hospital Complex Of Vigo,
Hospital Universitario de Gran Canaria Doctor Negrín,
Servicio Gallego de Salud,
Universidade de Vigo
ORCID:
0000-0002-0797-5391
Observed ORCID:
0000-0002-0797-5391
OpenAlex ID:
A5008733889
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
2020
·
Carlos Rafael-Vidal
, Nair Pérez
, et al.
·
International Journal of Molecular Sciences
·
76
PDF
Switching between reference adalimumab and biosimilars in chronic immune‐mediated inflammatory diseases: A systematic literature review
2021
·
Nerea García‐Beloso
, Irene Altabás‐González
, et al.
·
British Journal of Clinical Pharmacology
·
52
PDF
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
2021
·
Carlos Rafael-Vidal
, Irene Altabás
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner
2023
·
Carlos Rafael-Vidal
, Sara Martínez-Ramos
, et al.
·
Frontiers in Immunology
·
18
PDF
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients
2024
·
Irene Altabás-González
, José María Pego-Reigosa
, et al.
·
Rheumatology
·
17
PDF
Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology
2022
·
José María Pego-Reigosa
, Carlos Peña-Gil
, et al.
·
BMC Health Services Research
·
15
PDF
Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis
2024
·
Irene Altabás-González
, Iñigo Rua-Figueroa
, et al.
·
Lupus Science & Medicine
·
11
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
2021
·
Beatriz Tejera Segura
, Irene Altabás González
, et al.
·
Rheumatology
·
10
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry
2026
·
Paola Vidal-Montal
, Aina Fabregat
, et al.
·
Lupus Science & Medicine
·
8
PDF
Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort
2022
·
Irene Altabás-González
, Iñigo Rúa-Figueroa
, et al.
·
Rheumatology
·
7
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality
2025
·
Irene Altabás-González
, Iñigo Rua-Figueroa
, et al.
·
Lupus Science & Medicine
·
5
PDF
How to investigate: Suspected systemic rheumatic diseases in patients presenting with muscle complaints
2019
·
Irene Altabás-González
, Naír Pérez-Gómez
, et al.
·
Best Practice & Research Clinical Rheumatology
·
5
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
2022
·
Oscar J. Cordero
, Irene Viéitez
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
4
PDF
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry
2025
·
Tatiana Cobo-Ibáñez
, Ivan Castellví
, et al.
·
Arthritis Research & Therapy
·
3
PDF
Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus
2024
·
Carlos Rafael-Vidal
, Sara Martínez-Ramos
, et al.
·
Arthritis Research & Therapy
·
3
PDF
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?
2023
·
Irene Altabás-González
, Íñigo Rúa-Figueroa
, et al.
·
Rheumatology
·
3
PDF
LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
2023
·
Irene Altabás-González
, José María Pego-Reigosa
, et al.
·
Lupus Science & Medicine
·
2
PDF
LP-171 Fibromyalgia and glucocorticoids use drives self-perceived depression in systemic lupus erythematosus: insights from a large prospective and multicenter study using Relesserpros register’s database.
2023
·
Iñigo Rúa-Figueroa
, Julia Martínez-Barrio
, et al.
·
Lupus Science & Medicine
·
2
PDF
Tobacco smoking is an independent factor associated with retinal damage in systemic lupus erythematosus: a cross-sectional and retrospective study
2019
·
Iñigo Rúa-Figueroa
, Celia Erausquin
, et al.
·
Rheumatology International
·
2
Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?
2024
·
Iñigo Rua-Figueroa
, Irene Altabás-González
, et al.
·
Rheumatology
·
1
LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort
2023
·
Irene Altabás-González
, José María Pego-Reigosa
, et al.
·
Lupus Science & Medicine
·
1
PDF
Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry
2026
·
Jesús Loarce-Martos
, José Luis Tandaipan
, et al.
·
Seminars in Arthritis and Rheumatism
PO:11:281 Spanish real-world ambispective multicenter registry of anifrolumab in systemic lupus erythematosus: efficacy and safety at 3- and 6-month follow-up (ANIFRO-reu study)
2026
·
Iñigo Rua-Figueroa
, Tarek Carlos Salman-Monte
, et al.
·
Lupus Science & Medicine
PDF
Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry
2026
·
Beatriz Frade-Sosa
, José A Gómez-Puerta
, et al.
·
Rheumatology
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data
2026
·
Inigo Rua-Figueroa
, Julia Martínez-Barrio
, et al.
·
BMC Rheumatology
Show more works
View as search
Works count:
28
Citation count:
297
H-index:
8
I10-index:
8
Year
Topic
Type